Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma (Q39402166)

11 September 2017

title

Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma (English)

1 reference

11 September 2017

0 references

Tetsuo Takehara

1 reference

11 September 2017

Naoki Hiramatsu

1 reference

11 September 2017

Tomohide Tatsumi

1 reference

11 September 2017

Takuya Miyagi

1 reference

11 September 2017

Keisuke Kohga

1 reference

11 September 2017

Hinako Tsunematsu

1 reference

11 September 2017

Satoshi Aono

1 reference

11 September 2017

Satoshi Shimizu

1 reference

11 September 2017

Hayato Hikita

1 reference

11 September 2017

Masashi Yamamoto

1 reference

11 September 2017

Tsugiko Oze

1 reference

11 September 2017

Hiroshi Aketa

1 reference

11 September 2017

Atsushi Hosui

1 reference

11 September 2017

Hisashi Ishida

1 reference

11 September 2017

Tatsuya Kanto

1 reference

11 September 2017

Norio Hayashi

1 reference

11 September 2017

publication date

1 September 2012

1 reference

Cancer Immunology, Immunotherapy

11 September 2017

published in

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

1425-1432

1 reference

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Host genetic factors influence disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Cytokine gene polymorphism in human disease: on-line databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Gene polymorphisms, inflammatory diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

NKG2D in NK and T cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

The role of the NKG2D receptor for tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Innate and adaptive lymphoid cells in the human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Immunology of the healthy liver: old questions and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Tumor-associated MICA is shed by ADAM proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

The ADAMs family of metalloproteases: multidomain proteins with multiple functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

IL-1 pathways in inflammation and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Soluble MICA in malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1208-6

10.1007/S00262-012-1208-6

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference